Response of bidimensionally measurable metastases to flutamide withdrawal in a patient with advanced prostate cancer.
Warren
G P
GP
Genitourinary Interdisciplinary Program, Indiana University Cancer Center, USA.
Roth
B J
BJ
D000230:Adenocarcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects*; D005485:Flutamide / Q000009:adverse effects*; D006801:Humans; D006869:Hydronephrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008297:Male; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D011471:Prostatic Neoplasms / Q000473:pathology*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D014057:Tomography, X-Ray Computed
D000726:Androgen Antagonists; D005485:Flutamide